Clemson AD, students at odds over proposed ticket costs

Clemson athletics director Dan Radakovich 

CLEMSON — The NCAA has given Clemson an extension for its appeal on a performance enhancing drug case in which three football players failed drug tests just before the Dec. 29 Cotton Bowl. 

Clemson was scheduled to present its appeal to the NCAA next week, 45 days after B samples came back positive, but the university's legal team said it needs more time.

The NCAA granted Clemson an additional 45 days.

"We're working through that process right now," athletic director Dan Radakovich said Friday. "It's just very slow because it's kind of out of our hands. We've sent some things off to be tested and the results haven't come back yet." 

The three football players, former defensive tackle Dexter Lawrence, tight end Braden Galloway and Zach Giella all tested positive for ostarine ahead of the College Football Playoff. 

Fewer than 20 Clemson players were tested before the Cotton Bowl. The Tigers have 119 players on their roster.

Ostarine is a PED not approved for human use and is only found in illegal products, though manufacturers have been known to illegally put the drug in supplements without disclosing that information. 

Radakovich said Clemson has sent materials to a lab for analysis, adding he doesn't know when results will be available. He declined to expand on what exactly is being tested. 

Follow Grace Raynor on Twitter @gmraynor

Grace is the Post and Courier's Clemson reporter. She graduated from the University of North Carolina with a degree in journalism.